The level of this protein was found to be inversely correlated with the autoantibodies raised against GABA-A-receptor-associated protein in the sera of patients, leading to the conclusion that GABARAP could be a new potential auto antigen in SPS, which could be damaging GABAergic pathway, pathogenetically involved in disease evolution. This evidence concerns the gene GABARAP and stiff-person syndrome.